General Information of Drug Off-Target (DOT) (ID: OT07YJW4)

DOT Name Solute carrier family 7 member 14 (SLC7A14)
Synonyms Gamma-aminobutyric acid transporter SLC7A14
Gene Name SLC7A14
Related Disease
Inherited retinal dystrophy ( )
Leber congenital amaurosis ( )
Leber congenital amaurosis 1 ( )
Retinitis pigmentosa 68 ( )
Retinitis pigmentosa ( )
Mesothelioma ( )
UniProt ID
S7A14_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
Pfam ID
PF13520 ; PF13906
Sequence
MSGFFTSLDPRRVQWGAAWYAMHSRILRTKPVESMLEGTGTTTAHGTKLAQVLTTVDLIS
LGVGSCVGTGMYVVSGLVAKEMAGPGVIVSFIIAAVASILSGVCYAEFGVRVPKTTGSAY
TYSYVTVGEFVAFFIGWNLILEYLIGTAAGASALSSMFDSLANHTISRWMADSVGTLNGL
GKGEESYPDLLALLIAVIVTIIVALGVKNSIGFNNVLNVLNLAVWVFIMIAGLFFINGKY
WAEGQFLPHGWSGVLQGAATCFYAFIGFDIIATTGEEAKNPNTSIPYAITASLVICLTAY
VSVSVILTLMVPYYTIDTESPLMEMFVAHGFYAAKFVVAIGSVAGLTVSLLGSLFPMPRV
IYAMAGDGLLFRFLAHVSSYTETPVVACIVSGFLAALLALLVSLRDLIEMMSIGTLLAYT
LVSVCVLLLRYQPESDIDGFVKFLSEEHTKKKEGILADCEKEACSPVSEGDEFSGPATNT
CGAKNLPSLGDNEMLIGKSDKSTYNVNHPNYGTVDMTTGIEADESENIYLIKLKKLIGPH
YYTMRIRLGLPGKMDRPTAATGHTVTICVLLLFILMFIFCSFIIFGSDYISEQSWWAILL
VVLMVLLISTLVFVILQQPENPKKLPYMAPCLPFVPAFAMLVNIYLMLKLSTITWIRFAV
WCFVGLLIYFGYGIWNSTLEISAREEALHQSTYQRYDVDDPFSVEEGFSYATEGESQEDW
GGPTEDKGFYYQQMSDAKANGRTSSKAKSKSKHKQNSEALIANDELDYSPE
Function
Imports 4-aminobutanoate (GABA) into lysosomes. May act as a GABA sensor that regulates mTORC2-dependent INS signaling and gluconeogenesis. The transport mechanism and substrate selectivity remain to be elucidated.
Tissue Specificity Expressed in skin fibroblasts.

Molecular Interaction Atlas (MIA) of This DOT

6 Disease(s) Related to This DOT
Disease Name Disease ID Evidence Level Mode of Inheritance REF
Inherited retinal dystrophy DISGGL77 Strong Genetic Variation [1]
Leber congenital amaurosis DISMGH8F Strong Genetic Variation [1]
Leber congenital amaurosis 1 DISY2B33 Strong Genetic Variation [1]
Retinitis pigmentosa 68 DISBF5TV Strong Autosomal recessive [2]
Retinitis pigmentosa DISCGPY8 Supportive Autosomal dominant [2]
Mesothelioma DISKWK9M Limited Genetic Variation [3]
------------------------------------------------------------------------------------
⏷ Show the Full List of 6 Disease(s)
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
This DOT Affected the Regulation of Drug Effects of 1 Drug(s)
Drug Name Drug ID Highest Status Interaction REF
3-iodothyronamine DM3L0F8 Investigative Solute carrier family 7 member 14 (SLC7A14) affects the uptake of 3-iodothyronamine. [10]
------------------------------------------------------------------------------------
5 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
Tretinoin DM49DUI Approved Tretinoin increases the expression of Solute carrier family 7 member 14 (SLC7A14). [4]
Cisplatin DMRHGI9 Approved Cisplatin affects the expression of Solute carrier family 7 member 14 (SLC7A14). [5]
Arsenic trioxide DM61TA4 Approved Arsenic trioxide increases the expression of Solute carrier family 7 member 14 (SLC7A14). [7]
Decitabine DMQL8XJ Approved Decitabine affects the expression of Solute carrier family 7 member 14 (SLC7A14). [5]
Bisphenol A DM2ZLD7 Investigative Bisphenol A increases the expression of Solute carrier family 7 member 14 (SLC7A14). [9]
------------------------------------------------------------------------------------
2 Drug(s) Affected the Post-Translational Modifications of This DOT
Drug Name Drug ID Highest Status Interaction REF
Arsenic DMTL2Y1 Approved Arsenic affects the methylation of Solute carrier family 7 member 14 (SLC7A14). [6]
Benzo(a)pyrene DMN7J43 Phase 1 Benzo(a)pyrene affects the methylation of Solute carrier family 7 member 14 (SLC7A14). [8]
------------------------------------------------------------------------------------

References

1 Phenotypic variability of SLC7A14 mutations in patients with inherited retinal dystrophy.Ophthalmic Genet. 2019 Apr;40(2):118-123. doi: 10.1080/13816810.2019.1586964. Epub 2019 Mar 29.
2 SLC7A14 linked to autosomal recessive retinitis pigmentosa. Nat Commun. 2014 Mar 27;5:3517. doi: 10.1038/ncomms4517.
3 Genetic variants associated with increased risk of malignant pleural mesothelioma: a genome-wide association study.PLoS One. 2013 Apr 23;8(4):e61253. doi: 10.1371/journal.pone.0061253. Print 2013.
4 Phenotypic characterization of retinoic acid differentiated SH-SY5Y cells by transcriptional profiling. PLoS One. 2013 May 28;8(5):e63862.
5 Acute hypersensitivity of pluripotent testicular cancer-derived embryonal carcinoma to low-dose 5-aza deoxycytidine is associated with global DNA Damage-associated p53 activation, anti-pluripotency and DNA demethylation. PLoS One. 2012;7(12):e53003. doi: 10.1371/journal.pone.0053003. Epub 2012 Dec 27.
6 Prenatal arsenic exposure and the epigenome: identifying sites of 5-methylcytosine alterations that predict functional changes in gene expression in newborn cord blood and subsequent birth outcomes. Toxicol Sci. 2015 Jan;143(1):97-106. doi: 10.1093/toxsci/kfu210. Epub 2014 Oct 10.
7 Essential role of cell cycle regulatory genes p21 and p27 expression in inhibition of breast cancer cells by arsenic trioxide. Med Oncol. 2011 Dec;28(4):1225-54.
8 Air pollution and DNA methylation alterations in lung cancer: A systematic and comparative study. Oncotarget. 2017 Jan 3;8(1):1369-1391. doi: 10.18632/oncotarget.13622.
9 Bisphenol A induces DSB-ATM-p53 signaling leading to cell cycle arrest, senescence, autophagy, stress response, and estrogen release in human fetal lung fibroblasts. Arch Toxicol. 2018 Apr;92(4):1453-1469.
10 Identification and characterization of 3-iodothyronamine intracellular transport. Endocrinology. 2009 Apr;150(4):1991-9.